annual cash & cash equivalents:
$4.01B-$4.07B(-50.37%)Summary
- As of today (May 29, 2025), TMO annual cash & cash equivalents is $4.01 billion, with the most recent change of -$4.07 billion (-50.37%) on December 31, 2024.
- During the last 3 years, TMO annual cash & cash equivalents has fallen by -$468.00 million (-10.45%).
- TMO annual cash & cash equivalents is now -61.17% below its all-time high of $10.32 billion, reached on December 31, 2020.
Performance
TMO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$4.13B+$125.00M(+3.12%)Summary
- As of today (May 29, 2025), TMO quarterly cash & cash equivalents is $4.13 billion, with the most recent change of +$125.00 million (+3.12%) on March 29, 2025.
- Over the past year, TMO quarterly cash & cash equivalents has dropped by -$1.36 billion (-24.82%).
- TMO quarterly cash & cash equivalents is now -65.63% below its all-time high of $12.03 billion, reached on September 1, 2021.
Performance
TMO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TMO Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -50.4% | -24.8% |
3 y3 years | -10.4% | +50.2% |
5 y5 years | +67.1% | +38.7% |
TMO Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -53.0% | at low | -51.5% | +119.0% |
5 y | 5-year | -61.2% | +67.1% | -65.6% | +119.0% |
alltime | all time | -61.2% | >+9999.0% | -65.6% | >+9999.0% |
TMO Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $4.13B(+3.1%) |
Dec 2024 | $4.01B(-50.4%) | $4.01B(-13.7%) |
Sep 2024 | - | $4.64B(-34.3%) |
Jun 2024 | - | $7.07B(+28.6%) |
Mar 2024 | - | $5.50B(-31.9%) |
Dec 2023 | $8.08B(-5.2%) | $8.08B(+31.3%) |
Sep 2023 | - | $6.15B(+96.3%) |
Jun 2023 | - | $3.13B(-10.0%) |
Mar 2023 | - | $3.48B(-59.2%) |
Dec 2022 | $8.52B(+90.4%) | $8.52B(+192.0%) |
Sep 2022 | - | $2.92B(+54.6%) |
Jun 2022 | - | $1.89B(-31.4%) |
Mar 2022 | - | $2.75B(-38.5%) |
Dec 2021 | $4.48B(-56.6%) | $4.48B(-62.8%) |
Sep 2021 | - | $12.03B(+71.3%) |
Jun 2021 | - | $7.02B(+25.8%) |
Mar 2021 | - | $5.58B(-45.9%) |
Dec 2020 | $10.32B(+330.4%) | $10.32B(+36.9%) |
Sep 2020 | - | $7.54B(+29.6%) |
Jun 2020 | - | $5.82B(+95.2%) |
Mar 2020 | - | $2.98B(+24.3%) |
Dec 2019 | $2.40B(+14.1%) | $2.40B(+88.5%) |
Sep 2019 | - | $1.27B(-44.4%) |
Jun 2019 | - | $2.29B(+106.9%) |
Mar 2019 | - | $1.11B(-47.4%) |
Dec 2018 | $2.10B(+57.5%) | $2.10B(+91.5%) |
Sep 2018 | - | $1.10B(+17.2%) |
Jun 2018 | - | $937.00M(-1.4%) |
Mar 2018 | - | $950.00M(-28.8%) |
Dec 2017 | $1.33B(+69.8%) | $1.33B(+80.1%) |
Sep 2017 | - | $741.10M(+21.3%) |
Jun 2017 | - | $611.00M(-14.3%) |
Mar 2017 | - | $713.30M(-9.2%) |
Dec 2016 | $786.00M(+73.9%) | $786.00M(-60.1%) |
Sep 2016 | - | $1.97B(+197.1%) |
Jun 2016 | - | $663.10M(-19.8%) |
Mar 2016 | - | $826.80M(+82.9%) |
Dec 2015 | $452.10M(-66.3%) | $452.10M(-10.2%) |
Sep 2015 | - | $503.40M(-34.5%) |
Jun 2015 | - | $768.40M(-11.1%) |
Mar 2015 | - | $864.60M(-35.6%) |
Dec 2014 | $1.34B(-76.9%) | $1.34B(+151.5%) |
Sep 2014 | - | $534.30M(-8.7%) |
Jun 2014 | - | $584.90M(-60.9%) |
Mar 2014 | - | $1.50B(-74.3%) |
Dec 2013 | $5.83B(+623.2%) | $5.83B(+215.7%) |
Sep 2013 | - | $1.85B(+31.0%) |
Jun 2013 | - | $1.41B(+40.3%) |
Mar 2013 | - | $1.00B(+24.6%) |
Dec 2012 | $805.60M(-20.7%) | $805.60M(-3.2%) |
Sep 2012 | - | $832.20M(+13.6%) |
Jun 2012 | - | $732.30M(-7.1%) |
Mar 2012 | - | $788.30M(-22.4%) |
Dec 2011 | $1.02B(+10.8%) | $1.02B(+14.2%) |
Sep 2011 | - | $890.30M(-34.3%) |
Jun 2011 | - | $1.36B(-51.4%) |
Mar 2011 | - | $2.79B(+204.1%) |
Dec 2010 | $917.10M(-41.4%) | $917.10M(-29.9%) |
Jun 2010 | - | $1.31B(-8.7%) |
Mar 2010 | - | $1.43B(-8.5%) |
Dec 2009 | $1.56B(+22.1%) | $1.56B(-10.4%) |
Sep 2009 | - | $1.75B(+23.2%) |
Jun 2009 | - | $1.42B(-9.2%) |
Mar 2009 | - | $1.56B(+21.9%) |
Dec 2008 | $1.28B(+104.8%) | $1.28B(+3.2%) |
Sep 2008 | - | $1.24B(+23.2%) |
Jun 2008 | - | $1.01B(+37.2%) |
Mar 2008 | - | $734.00M(+17.4%) |
Dec 2007 | $625.10M(-6.3%) | $625.10M(-24.8%) |
Sep 2007 | - | $830.80M(-12.7%) |
Jun 2007 | - | $951.20M(+41.8%) |
Mar 2007 | - | $670.90M(+0.5%) |
Dec 2006 | $667.40M | $667.40M(+322.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2006 | - | $157.96M(-16.7%) |
Jun 2006 | - | $189.72M(-17.8%) |
Mar 2006 | - | $230.79M(+7.7%) |
Dec 2005 | $214.33M(-34.4%) | $214.33M(+10.8%) |
Sep 2005 | - | $193.46M(+21.1%) |
Jun 2005 | - | $159.74M(-54.6%) |
Mar 2005 | - | $351.56M(+7.5%) |
Dec 2004 | $326.89M(+67.0%) | $326.89M(-2.6%) |
Sep 2004 | - | $335.66M(+9.5%) |
Jun 2004 | - | $306.62M(-13.1%) |
Mar 2004 | - | $352.99M(+80.3%) |
Dec 2003 | $195.77M(-42.3%) | $195.77M(-5.7%) |
Sep 2003 | - | $207.55M(-21.5%) |
Jun 2003 | - | $264.44M(+6.2%) |
Mar 2003 | - | $249.11M(-26.5%) |
Dec 2002 | $339.04M(+13.9%) | $339.04M(+45.1%) |
Sep 2002 | - | $233.60M(-0.6%) |
Jun 2002 | - | $234.91M(-25.4%) |
Mar 2002 | - | $315.00M(+5.9%) |
Dec 2001 | $297.56M(-41.1%) | $297.56M(-12.5%) |
Sep 2001 | - | $340.19M(-32.8%) |
Jun 2001 | - | $506.35M(+56.1%) |
Mar 2001 | - | $324.40M(-35.8%) |
Dec 2000 | $505.52M(+79.4%) | $505.52M(+57.5%) |
Sep 2000 | - | $320.96M(+14.1%) |
Jun 2000 | - | $281.17M(-47.3%) |
Mar 2000 | - | $533.47M(+89.3%) |
Dec 1999 | $281.80M(+5.0%) | $281.80M(-33.6%) |
Sep 1999 | - | $424.30M(+9.7%) |
Jun 1999 | - | $386.90M(-4.3%) |
Mar 1999 | - | $404.20M(+50.7%) |
Dec 1998 | $268.30M(-54.8%) | $268.30M(-35.5%) |
Sep 1998 | - | $416.10M(-31.9%) |
Jun 1998 | - | $611.00M(+2.6%) |
Mar 1998 | - | $595.70M(+0.4%) |
Dec 1997 | $593.60M(+43.2%) | $593.60M(+20.3%) |
Sep 1997 | - | $493.30M(+70.9%) |
Jun 1997 | - | $288.70M(-15.5%) |
Mar 1997 | - | $341.80M(-17.5%) |
Dec 1996 | $414.40M(-10.3%) | $414.40M(-18.2%) |
Sep 1996 | - | $506.50M(-6.4%) |
Jun 1996 | - | $541.20M(-30.1%) |
Mar 1996 | - | $774.70M(+67.7%) |
Dec 1995 | $462.00M(+20.7%) | $462.00M(+4.6%) |
Sep 1995 | - | $441.60M(-16.5%) |
Jun 1995 | - | $528.90M(+30.2%) |
Mar 1995 | - | $406.30M(+6.1%) |
Dec 1994 | $382.80M(+17.5%) | $382.80M(+24.6%) |
Sep 1994 | - | $307.20M(+6.0%) |
Jun 1994 | - | $289.70M(+12.5%) |
Mar 1994 | - | $257.60M(-20.9%) |
Dec 1993 | $325.70M(+70.9%) | $325.70M(-5.8%) |
Sep 1993 | - | $345.60M(+325.1%) |
Jun 1993 | - | $81.30M(-24.3%) |
Mar 1993 | - | $107.40M(-43.7%) |
Dec 1992 | $190.60M(+45.5%) | $190.60M(+14.7%) |
Sep 1992 | - | $166.20M(+22.7%) |
Jun 1992 | - | $135.50M(-7.5%) |
Mar 1992 | - | $146.50M(+11.8%) |
Dec 1991 | $131.00M(+11.1%) | $131.00M(+18.1%) |
Sep 1991 | - | $110.90M(+1.2%) |
Jun 1991 | - | $109.60M(-19.0%) |
Mar 1991 | - | $135.30M(+14.8%) |
Dec 1990 | $117.90M(+25.6%) | $117.90M(+40.0%) |
Sep 1990 | - | $84.20M(+68.7%) |
Jun 1990 | - | $49.90M(-27.9%) |
Mar 1990 | - | $69.20M(-26.3%) |
Dec 1989 | $93.90M(-31.2%) | $93.90M(+45.4%) |
Sep 1989 | - | $64.60M(-52.6%) |
Dec 1988 | $136.40M(-5.3%) | $136.40M(-5.3%) |
Dec 1987 | $144.10M(+125.9%) | $144.10M(+125.9%) |
Dec 1986 | $63.80M(+112.7%) | $63.80M(+112.7%) |
Dec 1985 | $30.00M(+163.2%) | $30.00M(+163.2%) |
Dec 1984 | $11.40M | $11.40M |
FAQ
- What is Thermo Fisher Scientific annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific annual cash & cash equivalents year-on-year change?
- What is Thermo Fisher Scientific quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific quarterly cash & cash equivalents year-on-year change?
What is Thermo Fisher Scientific annual cash & cash equivalents?
The current annual cash & cash equivalents of TMO is $4.01B
What is the all time high annual cash & cash equivalents for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high annual cash & cash equivalents is $10.32B
What is Thermo Fisher Scientific annual cash & cash equivalents year-on-year change?
Over the past year, TMO annual cash & cash equivalents has changed by -$4.07B (-50.37%)
What is Thermo Fisher Scientific quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TMO is $4.13B
What is the all time high quarterly cash & cash equivalents for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high quarterly cash & cash equivalents is $12.03B
What is Thermo Fisher Scientific quarterly cash & cash equivalents year-on-year change?
Over the past year, TMO quarterly cash & cash equivalents has changed by -$1.36B (-24.82%)